Inadequate follow-up for abnormal pap smears in an urban population

Journal of the National Medical Association

Volumn 95, Issue 9, 2003, Pages 825-832

  Peterson, Neeraja B ^a,b,d   Han, Jini ^a,c   Freund, Karen M ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Age groups; Cervical neoplasia; Cervix dysplasia; Ethnic groups; Papanicolaou smear; Racial stocks

Indexed keywords

ADULT; AGE; ARTICLE; ASIAN AMERICAN; CAUCASIAN; COHORT ANALYSIS; ETHNIC GROUP; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAID; MULTIVARIATE ANALYSIS; NEGRO; PAPANICOLAOU TEST; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RISK FACTOR; UNITED STATES; URBAN POPULATION; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BOSTON; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; REGRESSION ANALYSIS; URBAN POPULATION; VAGINAL SMEARS;

EID: 0141483823     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. All About Cervical Cancer. (Accessed February 12, 2003, at (http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?dt=8).
2. Cervix Uteri Cancer (Invasive). (Accessed February 12, 2003, at (http://seer.cancer.gov/csr/1973_1999/sections.html#sections).
3. Boston resident deaths, Massachusetts Department of Public Health.
4. Benard VB, Lee NC, Piper M, Richardson L. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States). Cancer Causes Control. 2001;12:61-68.
5. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA. 1992;267:1892.
6. Wright L, Freund KM. Final Technical Report. National Center of Excellence in Women's Health, Boston University School of Medicine, 1999.
7. Suh-Burgmann E, Darragh T, Smith-McCune, K. Atypical squamous cells of undetermined significance: management patterns at an academic medical center. Am J Obstet Gynecol. 1998;178:991-995.
8. National Guideline Clearinghouse. (Accessed November 2, 2000, at http://www.guideline.gov/VIEWS/summary.asp?guideline=1187&summary_type= full_summary&view=full_summary&sSearch_string=).
9. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA. 1994;271:1866-1869.
10. Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J. 1992;85:5-8.
11. Cartwright PS, Reed G. No-show behavior in a county hospital clinic. Am J Gynecol Health. 1990;6:15-21.
12. Marcus AC, Crane LA, Kaplan CP, Reading AE, Savage E, Gunning J. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30:216-229.
13. Lane DS. Compliance with referral from a cancer-screening project. J Fam Pract. 1983;15:811-817.
14. Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in Manchester. BMJ. 1988;296:1041-1042.
15. Paskett ED, White E, Carter W, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19:630-641.
16. Carey P, Gjerdingen DK. Follow-up of abnormal papanicolaou smears among women of different races. J Fam Pract. 1993;37:583-587.
17. Frisch LE. Effectiveness of a case management protocol in improving follow-up and referral of Papanicolaou smears indicating cervical intraepithelial neoplasia. J Am Coll Health. 1986;35:112-115.
18. Paskett ED, Carter WB, Chu J, White E. Compliance behavior in women with abnormal Pap smears. Med Care. 1990;28:643-656.
19. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med. 1999;8:129-134.
20. Michielutte R, Diseker RA, Young LD, May WJ. Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med. 1985;14:248-258.
21. Fruchter RG, Boyce J, Hunt M. Missed opportunities for early diagnosis of cancer of the cervix. Am J Public Health 1980;70:418-420.
22. Janerich DT; Hadjimichael O, Schwartz PE, Lowell DM, Meigs JW, Merino MJ, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 1995;85:791-794.